Study S001452

The Correlation Between Par-4 and Telomere-telomerase System in the New Dignosised Type 2 Diabetes Patients Who Received GLP-1 Analog or Metformin Treatment

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02535299
Acronym: Par-4；GLP-1
Study type: INTERVENTIONAL
Phase: PHASE4
Masking: NONE
Status: UNKNOWN
Enrollment: 200
Start: 2016-06
Primary completion: 2018-12
Lead sponsor: Third Military Medical University
Conditions: GLP-1；Metformin；Telomere-telomerase System；Par-4
Interventions: DRUG:Liraglutide; DRUG:Metformin
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

physiological parameter:glycosylated hemoglobin A1c [up to 6 months;]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.